![](/img/cover-not-exists.png)
71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours
Tan, D, Ng, M, Subbiah, V, Messersmith, W, Teneggi, V, Diermayr, V, Ethirajulu, K, Yeo, P, Gan, B H, Lee, L H, Blanchard, S, Nellore, R, Yasin, M, Umrani, D, Lee, M A, Hill, J, Madan, B, Virshup, D, MVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy430.002
Date:
November, 2018
File:
PDF, 112 KB
english, 2018